SOURCE: Kadmon Corporation

Kadmon Corporation

November 25, 2014 10:30 ET

Kadmon Corporation to Present at Two Upcoming Investor Conferences

NEW YORK, NY--(Marketwired - Nov 25, 2014) - Kadmon Corporation, LLC, today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer, will present an overview of Kadmon and its clinical and commercial programs at two upcoming investor conferences:

  • 26th Annual Piper Jaffray Healthcare Conference on Wednesday, December 3rd at 9:50 a.m. ET in New York City
  • 25th Annual Oppenheimer Healthcare Conference on Thursday, December 11th at 11:30 a.m. ET in New York City

A live audio webcast of the Oppenheimer presentation will be accessible through the conference website at The webcast will be archived for 90 days.

About Kadmon Corporation
Kadmon Corporation, LLC, is a vertically integrated biopharmaceutical company focused on developing innovative products for significant unmet medical needs. We have a diversified product pipeline in oncology, immunological and neurologic diseases and fibrosis, monogenic diseases and metabolic disease. For more information, visit

This press release contains forward-looking statements. These forward-looking statements are based on management's expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. The information contained in this press release is believed to be current as of the date of original issue. Kadmon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

Contact Information